Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
Major depressive disorder is a psychiatric disease having approximately a 20% lifetime prevalence in adults in the United States (U.S.), as reported by Hasin et al. in <i>JAMA Psichiatry</i> 2018 <i>75</i>, 336−346. Symptoms include low mood, anhedonia, decreased en...
Main Authors: | Cecilia Muraro, Marco Dalla Tiezza, Chiara Pavan, Giovanni Ribaudo, Giuseppe Zagotto, Laura Orian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/9/17/3631 |
Similar Items
-
Antioxidant Chimeric Molecules: Are Chemical Motifs Additive? The Case of a Selenium-Based Ligand
by: Davide Zeppilli, et al.
Published: (2023-07-01) -
Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design
by: Giovanni Ribaudo, et al.
Published: (2020-08-01) -
The <sup>125</sup>Te Chemical Shift of Diphenyl Ditelluride: Chasing Conformers over a Flat Energy Surface
by: Marco Bortoli, et al.
Published: (2019-03-01) -
Psychiatric Disorders and Oxidative Injury: Antioxidant Effects of Zolpidem Therapy disclosed In Silico
by: Marco Bortoli, et al.
Published: (2019-01-01) -
Comparison of Serum BDNF changes in Women with Major Depressive Disorder Treated with Fluoxetine and Cognitive Behavioral Therapy: A Randomized Clinical Trial
by: Mehrdad Jallalian, et al.
Published: (2023-11-01)